- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
MSD Pharma likely to participate in global tender for procurement of HPV vaccine against cervical cancer
The Union Health Ministry is likely to float a global tender for HPV in April for 16.02 crore doses to be procured by 2026.
New Delhi: MSD Pharmaceuticals is willing to participate in a global tender that the Union Health Ministry is likely to float in April to procure HPV vaccine against cervical cancer for immunisation of girls aged 9 to 14. MSD Pharmaceuticals Private Limited, a wholly-owned subsidiary of Merck Sharp and Dohme (known as Merck and Co Inc in the US and Canada), sells its HPV vaccine Gardasil...
New Delhi: MSD Pharmaceuticals is willing to participate in a global tender that the Union Health Ministry is likely to float in April to procure HPV vaccine against cervical cancer for immunisation of girls aged 9 to 14. MSD Pharmaceuticals Private Limited, a wholly-owned subsidiary of Merck Sharp and Dohme (known as Merck and Co Inc in the US and Canada), sells its HPV vaccine Gardasil 4 (quadrivalent vaccine) in India. It is currently priced at Rs 3,927 per dose.
Read also: Govt likely to float global tender for HPV vaccine in April; Serum Institute, Merck may participate
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751